Gefitinib Medac

Gefitinib Medac is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Medac is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or returned. It works by targeting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is specifically indicated for cancers that test positive for EGFR mutations.

Common effects of Gefitinib Medac may include skin rash, diarrhea, and dry skin. Some users may also experience nausea, loss of appetite, or fatigue. These effects can vary from person to person and are not exhaustive.

Gefitinib Medac should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication.

Gefitinib Medac may interact with other medications, including those that are metabolized by the liver. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.